Frontlight ResearchEarly access
Trial site
RWJBarnabas Health- Jersey City Medical Center
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Metastatic breast cancer2 trials
- Childhood cancers1 trial
- Head and neck cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 22 trials
- Phase 31 trial
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Rutgers, The State University of New Jersey3 trials
- Mridula George, MD1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
Running trials
Recruiting
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Active, not recruiting
OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer
Recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Active, not recruiting
Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Head and neck cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026